Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Feb 18;110(4):1081-7.
doi: 10.1038/bjc.2013.805. Epub 2014 Jan 14.

Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial

M R Wevers  1 , N K Aaronson  2 , S Verhoef  3 , E M A Bleiker  4 , D E E Hahn  5 , M A Kuenen  2 , J van der Sanden-Melis  6 , T Brouwer  6 , F B L Hogervorst  7 , R B van der Luijt  6 , H B Valdimarsdottir  8 , T van Dalen  9 , E B M Theunissen  10 , B van Ooijen  11 , M A de Roos  12 , P J Borgstein  13 , B C Vrouenraets  14 , E Vriens  15 , W H Bouma  16 , H Rijna  17 , J P Vente  18 , A J Witkamp  19 , E J T Rutgers  20 , M G E M Ausems  6
Affiliations
Randomized Controlled Trial

Impact of rapid genetic counselling and testing on the decision to undergo immediate or delayed prophylactic mastectomy in newly diagnosed breast cancer patients: findings from a randomised controlled trial

M R Wevers et al. Br J Cancer. .

Abstract

Background: Female breast cancer patients with a BRCA1/2 mutation have an increased risk of contralateral breast cancer. We investigated the effect of rapid genetic counselling and testing (RGCT) on choice of surgery.

Methods: Newly diagnosed breast cancer patients with at least a 10% risk of a BRCA1/2 mutation were randomised to an intervention group (offer of RGCT) or a control group (usual care; ratio 2 : 1). Primary study outcomes were uptake of direct bilateral mastectomy (BLM) and delayed contralateral prophylactic mastectomy (CPM).

Results: Between 2008 and 2010, we recruited 265 women. On the basis of intention-to-treat analyses, no significant group differences were observed in percentage of patients opting for a direct BLM (14.6% for the RGCT group vs 9.2% for the control group; odds ratio (OR) 2.31; confidence interval (CI) 0.92-5.81; P=0.08) or for a delayed CPM (4.5% for the RGCT group vs 5.7% for the control group; OR 0.89; CI 0.27-2.90; P=0.84). Per-protocol analysis indicated that patients who received DNA test results before surgery (59 out of 178 women in the RGCT group) opted for direct BLM significantly more often than patients who received usual care (22% vs 9.2%; OR 3.09, CI 1.15-8.31, P=0.03).

Interpretation: Although the large majority of patients in the intervention group underwent rapid genetic counselling, only a minority received DNA test results before surgery. This may explain why offering RGCT yielded only marginally significant differences in uptake of BLM. As patients who received DNA test results before surgery were more likely to undergo BLM, we hypothesise that when DNA test results are made routinely available pre-surgery, they will have a more significant role in surgical treatment decisions.

Trial registration: ClinicalTrials.gov NCT00783822.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study profile/CONSORT diagram.
See this image and copyright information in PMC

References

    1. Ardern-Jones A, Kenen R, Eeles R. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40. Eur J Cancer Care (Engl) 2005;14 (3:272–281. - PubMed
    1. Comprehensive Cancer Center the Netherlands (IKNL) 2008. Breast cancer guideline 1.1 www.oncoline.nl/mammacarcinoom .
    1. Drageset S, Lindstrom TC, Giske T, Underlid K. Being in suspense: women's experiences awaiting breast cancer surgery. J Adv Nurs. 2011;67 (9:1941–1951. - PubMed
    1. Evans DG, Lalloo F, Ashcroft L, Shenton A, Clancy T, Baildam AD, Brain A, Hopwood P, Howell A. Uptake of risk-reducing surgery in unaffected women at high risk of breast and ovarian cancer is risk, age, and time dependent. Cancer Epidemiol Biomarkers Prev. 2009;18 (8:2318–2324. - PubMed
    1. Evans DG, Lalloo F, Hopwood P, Maurice A, Baildam A, Brain A, Barr L, Howell A. Surgical decisions made by 158 women with hereditary breast cancer aged <50 years. Eur J Surg Oncol. 2005;31 (10:1112–1118. - PubMed

Publication types

Associated data